Lodo Therapeutics Obtains $17,000,000 Series A Funding

  • Feed Type
  • Date
    1/13/2016
  • Company Name
    Lodo Therapeutics
  • Mailing Address
    Undisclosed New York, NY 10023 USA
  • Company Description
    Lodo Therapeutics’ office and lab headquarters will be located within Accelerator’s facilities at the Alexandria Center for Life Science, New York City’s first and only premier life science park.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $17,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    AbbVie Biotech Ventures
  • Venture Investor
    Alexandria Venture Investments
  • Venture Investor
    ARCH Venture Partners
  • Venture Investor
    Harris & Harris Group
  • Venture Investor
    Innovate Partners
  • Venture Investor
    Johnson & Johnson Development Corporation
  • Venture Investor
    Partnership for New York City Fund
  • Venture Investor
    Pfizer Venture Investments
  • Venture Investor
    WuXi PharmaTech
  • Venture Investor
    Undisclosed

Trending on Xconomy